Insulet Reports Third Quarter 2018 Revenue of $151.1 Million, Up 24% Year-Over-Year, and Gross Margin Over 67%, Up 700 Basis Points

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Insulet Reports Third Quarter 2018 Revenue of $151.1 Million, Up 24% Year-Over-Year, and Gross Margin Over 67%, Up 700 Basis Points

Insulet (PODD) Tops Q3 EPS by 3c, Revenues Beat; Offers FY18 Revenue Outlook Above Consensus

November 1, 2018 4:06 PM EDT

Insulet (NASDAQ: PODD) reported Q3 EPS of $0.03, $0.03 better than the analyst estimate of $0.00. Revenue for the quarter came in at $151.1 million versus the consensus estimate of $149.36 million.

Third quarter revenue of $151.1 million, up 24%, compared to revenue of $121.8 million in the prior year, and guidance of $144.5 to $151.5 millionU.S. Omnipod revenue of $82.0 million, an increase of 17%International Omnipod revenue of $50.2 million, an increase of 55%Drug... More